Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020

Using payment data disclosed by 92 major pharmaceutical companies, this study evaluated personal payments to executive board members (EBMs) among each specialized field of internal medicine in Japan. A total of 63,405 personal payments worth of $70,796,014 in payment amounts were made to 99.2% of all EBMs of the 15... Show more